| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Elesclomol | GDSC1000 | pan-cancer | AAC | 0.027 | 0.4 |
| mRNA | ATRA | GDSC1000 | pan-cancer | AAC | -0.027 | 0.4 |
| mRNA | Sunitinib | CTRPv2 | pan-cancer | AAC | -0.028 | 0.4 |
| mRNA | navitoclax:birinapant (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | 0.029 | 0.4 |
| mRNA | RO-3306 | GDSC1000 | pan-cancer | AAC | 0.027 | 0.4 |
| mRNA | CP466722 | GDSC1000 | pan-cancer | AAC | -0.023 | 0.4 |
| mRNA | PD318088 | CTRPv2 | pan-cancer | AAC | -0.028 | 0.4 |
| mRNA | CCT018159 | GDSC1000 | pan-cancer | AAC | 0.027 | 0.4 |
| mRNA | PRIMA-1-Met | CTRPv2 | pan-cancer | AAC | -0.041 | 0.4 |